Stay updated on Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.

Latest updates to the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page
- Check2 days agoChange DetectedPublications section now lists a 2025 peer‑reviewed article (Murugavel et al., Diabetes Obes Metab) about the trial. The study record history has been updated to reflect this publication.SummaryDifference0.5%

- Check9 days agoNo Change Detected
- Check31 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference4%

- Check38 days agoChange DetectedRemoved several important MedlinePlus topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) and added a new version tag (v3.1.0).SummaryDifference0.7%

- Check45 days agoChange DetectedAdded a new Publications entry referencing a recent PubMed article on empagliflozin and beta-cell preservation in women with recent gestational diabetes; no deletions were made.SummaryDifference4%

- Check52 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; a 'Back to Top' UI element was removed (minor UI change).SummaryDifference0.3%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%

Stay in the know with updates to Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.